The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...
The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...
The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the ...
A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings ...
Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...
The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...
The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and ...
The FTC sued the three PBMs in September, accusing them of running an illicit drug rebate system that artificially raised the prices of insulin products.
The Federal Trade Commission has paused an enforcement action alleging pharmacy benefit managers used illegal rebate programs ...
The FTC in September sued the three companies, which it says together administer 80% of all prescriptions in the U.S., accusing them of unfairly limiting access to insulin drugs with lower list ...
(Reuters) -The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will likely move forward again after being paused amid President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback